Banque Pictet & Cie’s Exact Sciences EXAS Stock Holding History

Banque Pictet & Cie’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-86,668	Closed	-$4.74M	–	412
2025 Q3	$4.74M	Hold	86,668	–	–	0.03%	157
2025 Q2	$4.61M	Buy	+86,668	New	+$4.4M	0.03%	150
2024 Q2	–	Sell	-57,164	Closed	-$3.95M	–	321
2024 Q1	$3.95M	Buy	+57,164	New	+$3.62M	0.04%	164

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Banque Pictet & Cie's EXAS Position: Q1 2026 in Review

Banque Pictet & Cie sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 45,415 shares — an estimated $4.61M sold.

Banque Pictet & Cie first reported a position in EXAS in Q4 2019 and held it in 25 quarters. The position peaked at $49.1M in Q2 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

Banque Pictet & Cie reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
Banque Pictet & Cie sold 45,415 Exact Sciences shares in Q1 2026, an estimated $4.61M.
Banque Pictet & Cie first reported a position in Exact Sciences in Q4 2019 and held it in 25 quarters.
Banque Pictet & Cie's Exact Sciences position peaked at $49.1M in Q2 2021.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Banque Pictet & Cie's 13F filing for Q1 2026, filed 14 Apr 2026.